Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus for RPF
NCT04047576Phase 3Completed
- Sponsor
- Peking University International Hospital
- Start
- Jul 2018
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in Idiopathic retroperitoneal fibrosis (RPF), sponsored by Peking University International Hospital. Started Jul 2018; status: completed.
02
Drugs
sirolimus
03
Conditions
Idiopathic retroperitoneal fibrosis (RPF)
Beyond the preview
Go deeper on NCT04047576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04047576.